Michael Davidoff is responsible for Phreesia’s go-to-market strategy and oversees Phreesia’s Marketing, Business Development and Sales and Marketing Operations teams.
Before joining Phreesia, Michael held research and product development roles at the March of Dimes, where he led informatics initiatives and published epidemiology studies in peer-reviewed journals. Prior to that, he was with Merck & Co., where he studied the feasibility of drug-delivery targets. Michael earned an MPH from the University of Minnesota and a BS in Biophysics from Boston College.